SynthesisEuropean journal of clinical pharmacology2022

The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis.

Carlos Alves et al.PubMed ↗Publisher ↗

No numbers read from the abstract.